Sarepta Therapeutics Zooms Higher on Early Data Rally Promising
Sarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
Stock indices represent aggregated price movements of selected groups of stocks, signaling market trends and sentiment for analysis.
16,340 articlesSarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
Occidental Petroleum surges in 2026 on debt cleanup after the OxyChem sale, with oil prices supportive but questions ...
Markets react after macquarie downgrades paypal cost-saving plan, citing a back-loaded path to benefits. Investors fo...
Qualcomm exploded higher, gaining about 70% in a single month as it pivots toward AI data-center demand. Investors ar...
NVIDIA's market value has surged as AI infrastructure demand powers a relentless rally. A single metric—this insane n...
Two ad-tech leaders with different business models, The Trade Desk and AppLovin, reveal distinct quarterly revenue pa...
A billionaire investor backed D-Wave Quantum in late 2024, and the stock has surged and slumped in a choppy 2026 trad...
Tesla commands a large slug of XLY, giving the fund a distinct risk/reward profile compared with VCR. In the past fiv...
As Target prepares for its Q1 2026 earnings call, savvy investors want clarity on sales growth, margins, and the path...
As AI accelerates, the stock narrative centers on NVIDIA, AMD, and Broadcom. This guide breaks down why each could de...
A comprehensive, reader-friendly analysis of CVV's Q4 2025 earnings transcript. Learn how revenue trends, margins, an...
As Bank Montreal prepares to report its Q2 2026 results, investors want clarity on growth, credit quality, and return...